Lyell Immunopharma, Inc. (LYEL)

SEC filing

Lyell Immunopharma, Inc.

LYEL · CIK 1806952

4 · Sep 10, 2026 · Chief Medical Officer Aguirre Jarrad Mattieu was granted 47.50K Option (right to buy)

Chief Medical Officer Aguirre Jarrad Mattieu was granted 47.50K Option (right to buy)

xslF345X06/form4-09102026_110951.xml

xslF345X06/form4-09102026_110951.xmlSEC.gov

Graphics and non-inline formats (not embedded below).